Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session IV: BTKi in the Treatment of CLL
Is MRD Status Useful In Stopping/Continuing Therapy In CLL?
Wednesday, July 20, 2022
4:30 PM – 4:50 PM
Speaker(s)
Nitin Jain, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas